Posted: January 30th, 2017 | Author: DoseSpot | Filed under: Basics, Public Policy | Tags: e-Prescribing, e-Prescribing Platform, e-Prescribing Registration, e-Prescribing Software, e-Prescribing Solution, e-Prescribing State Mandates, New York e-Prescribing Mandate, New York e-Prescribing Registration, New York e-Prescribing Renewal, New York e-Prescribing Vendor Registration, New York e-Prescribing Vendor Renewal, New York Mandate, New York State Dental Association, New York State Department of Health, New York State Mandate, Registration for Official Prescriptions and e-Prescribing Systems, ROPES, State Mandates | No Comments »
If you are a prescriber in the state of New York, you probably know by now that electronic prescribing (e-Prescribing) of both controlled and non-controlled substances has been mandatory since March 27, 2016. As part of this mandate, all prescribers who will be sending controlled substances are required to register their e-Prescribing software as well as report to the controlled drug registry each time a controlled medication is prescribed or dispensed. In order for users to access the registry, the prescriber must first create an online Health Commerce System (HCS) account. Once the HCS account is active, the prescriber can then access ROPES to register their certified electronic prescribing software application for controlled substances.
The good news is that applying for an HCS account is as easy as filling out an online form and having a New York State driver’s license (or photo ID).
Applying for an HCS Account
Requirements: New York state valid driver’s license or photo ID and New York State Education Department registered medical professional license
To apply, you will need to access the following page: https://apps.health.ny.gov/pub/top.html
After you have applied and have been granted an HCS account, you will be able to sign back in via this link: https://commerce.health.state.ny.us
You may also use the following link as a reference to see in full detail a direct guide of the application process: https://apps.health.ny.gov/pub/ctrldocs/paperless_docp.pdf
In addition to requiring an account in the Health Commerce System (HCS), if prescribers intend to order controlled substances electronically, they will also need to register their certified electronic prescribing application software with the New York State Department of Health, Bureau of Narcotic Enforcement (BNE). This is done by filling out a ROPES form online through an HCS account.
What is a ROPES form?
A ROPES form is a new online application that allows the practitioner/organization to renew their registration for the Official Prescription Program and register their certified electronic prescribing software application for controlled substances. ROPES stands for Registration for Official Prescriptions and E-prescribing Systems. Only the prescriber can access the ROPES application.
Pre-requisite Requirements for ROPES
- Prescriber must be already registered with the Official Prescription Program (OPP)
- Prescriber must have an active DEA registration
- Prescriber must have an active NY license
- Prescriber must NOT be a registered Physician Assistant (PA) – PA’s must continue to submit the OPP registration form (DOH-4329) along with the PA Authorization Form (DOH-5054) to renew their OPP registration.
Completing the ROPES Form
In order for a prescriber to fill out a ROPES form, he/she must log into his/her HCS account (outlined above) by accessing the following weblink: https://commerce.health.state.ny.us and following the next few steps:
- Select “my content†at the top of the page
- Scroll down and select “All applicationsâ€
- Scroll over and select “Râ€
- Scroll down and select “ROPES†and complete the form
The ROPES form requires that the prescriber identifies the third party audit certifying organization and the date of the third party audit. Keep in mind that it is the software vendor that must be certified not the prescriber. The software vendor will supply all necessary information about this certification to the prescriber. The ROPES form must be renewed every two (2) years in order to remain valid. The prescriber must renew their OPP registration first via the one step process prior to renewing their current ROPES registration.
Questions?
Any questions regarding the ROPES form or the process can be directed to the BNE at narcotic@health.state.ny.us or by calling 1-866-811-7957.
For prescribers utilizing DoseSpot who have questions regarding the ROPES required third party audit information, please contact DoseSpot support at 888-847-6814.
Author: Shannon K.
Sources: Practice Fusion; New York State Dental Association; New York State Department of Health
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: January 27th, 2017 | Author: Shauna | Filed under: Basics, Dental, Digital Health, Medical, Telehealth | Tags: Dental, digital health, DoseSpot, DoseSpot e-Prescribing, Drummond Group, e-Prescribing, e-Prescribing Integration, e-Prescribing of Controlled Substances, e-Prescribing Software, e-Prescribing Solution, e-Prescribing Vendor, Electronic Health Record, Electronic Medical Record, electronic prescribing, EPCS, Healthcare Software, Healthcare Software Companies, Medical, Practice Management, surescripts, telehealth | No Comments »
Now that you’re well-versed in the world of e-Prescribing, let’s go one step further and prepare you for your own health care software’s e-Prescribing journey.
Here are some helpful tools to get you started.
The DoseSpot e-Prescribing Integration Tool Kit reviews everything you need to know about e-Prescribing integrations and what a partnership with DoseSpot e-Prescribing entails. Specifically, you will learn:
- DoseSpot’s e-Prescribing Integration Platforms: Integration JumpStart and Integration Plus+
- The markets we serve: Medical, Dental, and Digital Health
- Development features, functionality, and API
- Integration project cycles
- The benefits of partnering with DoseSpot
Get your copy here.
With more than 150 e-Prescribing integrations under our belt, we know a thing or two about what an e-Prescribing integration requires. In our How to Prepare Guide, we take the guesswork out by providing you with the following information:
- Specific patient demographic requirements
- Character limits and field requirements
- How to correctly transmit patient demographic information from your health care software to DoseSpot
Get your copy here.
Need more information? Feel free to schedule a meeting with us!
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: January 27th, 2017 | Author: DoseSpot | Filed under: Basics, Dental | Tags: Dental, Dental e-Prescribing, Dental Software Companies, Dental Support Organizations, DSOs, e-Prescribing, e-Prescribing Benefits, e-Prescribing Integration, e-Prescribing of Controlled Substances, e-Prescribing Software, e-Prescribing Solution, e-Prescribing Value, Electronic Dental Record, electronic prescribing, EPCS, Practice Management, Practice Management Software, Value Based Care | No Comments »
The role of oral health and its contribution to the population’s overall health, as well as the nation’s bottom line, has been in frequent discussions lately. With advocated access to dental care by a number of entities, governments and foundations, patients now understand that visiting their dentist is much more than receiving that fresh, clean feeling. It’s improving their quality of life.
However, with the ever increasing numbers of dentists and patients, along with Dental Support Organizations (DSOs) gaining significant prominence in the industry, the practice of dentistry is becoming more and more competitive. Patients now have more options to choose from when selecting their dentist and several factors weigh on their decision.
To align with this market shift, what is one component that the dental community can implement with ease to enhance their competitive advantage and attract and retain more patients? Or better yet, increase patient satisfaction, efficiency, and revenue, while simultaneously decreasing risks for dentists?
The solution: e-Prescribing.
Electronic Prescribing, known in short as e-Prescribing, has become a pertinent technology within dental practices that addresses the above conflicting goals. By incorporating e-Prescribing into the dental workflow at the point of patient engagement, several inherent efficiencies are presented:
1. Medication History
During a patient and dentist encounter, e-Prescribing enables dentists to verify a patient’s medication history and view up to two years of prescribed medications. This level of transparency allows for smarter treatment decisions and recognition of a patient who may be “doctor shopping” for controlled substances.
2. Safety
From a safety perspective, any drug-allergy or drug-drug interactions are flagged instantaneously while the clinical judgement of the dentist is still maintained if he/she elects to prescribe the medication. Dental-specific information such as a medication’s particular dental use, effects on dental treatment, and effects on bleeding are all seamlessly provided at point of care as well.
3. Productivity
With e-Prescribing, the totality of time to write a prescription for the patient is reduced from the traditional manual paper method, resulting in more time for direct interaction with the patient. The intrinsic productivity of e-Prescribing and its resulting patient interaction time may lead to incremental revenue as the opportunity is presented to discuss other dental issues and procedures.
4. Quality
Assessing e-Prescribing from a quality perspective, patient outcomes are significantly more accurate, consistent with quality initiates practiced in industry. It is getting it right the first time. As healthcare in general shifts to more measured and predictable patient outcomes, e-Prescribing goes a long way in addressing this new dynamic as it assists in providing a full panoramic view of a patient’s health.
5. Risk Reduction
Another benefit of e-Prescribing is risk reduction, especially when it comes to prescribing controlled substances. When controlled substances are electronically prescribed, the patient cannot lose the prescription or alter the dispense quantity or the medication itself. The prescription will be sent directly to the pharmacy with no chance of intermediaries touching it. In turn, this also banishes the need for paper prescription pads, thus eliminating the risk and liability involved with stolen prescription pads.
6. Patient Satisfaction
Perhaps the most significant aspect of the e-Prescribing equation is the increase in patient satisfaction. The extra time spent on dropping off and waiting for a prescription to be filled at the pharmacy is essentially eliminated as e-Prescribing diminishes the middle man and creates a seamless transaction for the patient.
7. Profitability
Due to improved efficiencies and increased patient satisfaction with e-Prescribing, a snowball effect is created relative to rising revenue. Not only will an increase in patient volume and retention occur, but administrative duties for office staff will lessen. Thanks to the more cost-effective vehicle of e-Prescribing, there will be no staff time required to manage the ordering and stocking of costly paper prescription pads and tamper-proof printing paper for controlled substances.
Overall, e-Prescribing is one tool in the dentist’s arsenal to meet the challenges of practicing dentistry today, which will allow for a more patient-centric strategy to be implemented, resulting in happier patients and dentists!
Author: Mark H.
Sources: Science Direct; Deming; Surescripts
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: January 26th, 2017 | Author: Jodi | Filed under: Basics, Controlled Substances, Dental, Digital Health, Medical, Telehealth | Tags: Drummond Group, e-Prescribing, e-Prescribing Basics, e-Prescribing Integration, e-Prescribing Software, e-Prescribing Vendor, EHR, EMR, End Users, Health Care IT, Health Care Software, health IT, healthcare IT, Healthcare Software, Practice Management Software, surescripts, White Labeled Solution | No Comments »
As we discussed in our previous post, e-Prescribing is the electronic transmission of a prescription from the prescriber’s device to the patient’s pharmacy of choice, therefore replacing the traditional paper prescription.
How does e-Prescribing work for end users?
While e-Prescribing software comes in many shapes and sizes, e-Prescribing integration is directly integrated into healthcare software such as an Electronic Health Record / Electronic Medical Record, telehealth application, or dental practice management solution. By way of integrating e-Prescribing into a healthcare software, the e-Prescribing platform becomes an integral component of a healthcare software’s product offering.
e-Prescribing integration seamlessly allows a prescriber to log into their existing healthcare software, select a patient, then search for, enter and send an e-Prescription for the patient in a few short steps. The process saves the prescriber time while improving patient outcomes.
What are the benefits of a custom, white labeled solution?
When an e-Prescribing solution is “white labeledâ€, this means the e-Prescribing user interface mirrors the look and feel of the healthcare software in which the e-Prescribing solution has been embedded. Colors, fonts, font sizes, layout – you name it – can all be completely customized to provide a seamless experience for end users.
Furthermore, mobile optimization has become a major trend as more healthcare software solutions are operating in the cloud and prescribers are accessing applications from multiple devices and multiple locations. This is why it’s important that the e-Prescribing functionality performs well in different environments, but most importantly, on smaller screens.
Responsive design is critical in ensuring that any e-Prescribing solution is accessible on every device. It’s the best one size fits all solution as this type of design allows the webpage to expand and contract in order to perfectly fit within any screen in both the traditional office and mobile settings. Ultimately, responsive design cuts down on development time as the e-Prescribing user interface does not need to be adjusted manually for each type of device (i.e. mobile, tablet, laptop, or desktop).
What does it take to cross the finish line and go live?
To go live with e-Prescribing and be able to send prescriptions electronically, all healthcare software companies must go through a Surescriptsâ„¢ e-Prescribing integration review. Surescripts operates the largest health information network that connects the diverse and expansive community of care partners nationwide, including pharmacies, providers, benefit managers, and health information exchanges.
As part of this e-Prescribing integration review, healthcare software companies will have to successfully execute various test scenarios during a web meeting with Surescripts. Test scenarios will be provided for the following services:
- NewRx: Route new prescriptions to the patient’s pharmacy of choice
- Refills: Receive prescription renewal requests and submit responses between doctor and pharmacy
- Medication History: View aggregated medication history data from pharmacies and pharmacy benefit managers (PBMs) upon receipt of patient consent.
- Prescription Benefit: Surescripts’ Prescription Benefit service puts eligibility, benefits and formulary information at a prescriber’s fingertips at the time of prescribing. This enables prescribers to select medications that are on formulary and are covered by the patient’s drug benefit.
- Electronic Prescribing of Controlled Substances (EPCS): Product has achieved Surescripts EPCS certification and has provided third-party audit documentation as required by the DEA.
Upon completion, healthcare software companies will be listed on the Surescripts website.
Healthcare software companies also looking for the ability to Electronically Prescribe Controlled Substances (EPCS) will need to go through a similar testing process with an approved e-Prescribing of Controlled Substances auditor such as the Drummond Group Inc., one of the first DEA approved certification bodies for EPCS.
Learn about DoseSpot’s e-Prescribing integration process by downloading our latest Integration Tool Kit.
Don’t miss the other parts of our e-Prescribing 101 series:
e-Prescribing 101, Part I: The Basics
e-Prescribing 101, Part II: Controlled Substances
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: January 26th, 2017 | Author: Shauna | Filed under: Basics, Controlled Substances, Dental, Digital Health, Medical, Telehealth | Tags: Addiction, Controlled Substances, e-Prescribing, e-Prescribing controlled substances, e-Prescribing Integration, e-Prescribing Software, e-Prescribing Vendor, EHR, EMR, EPCS, Health Care Software, Medication Schedules, Opioid Epidemic, Opioids, Practice Management Software, Scheduled Drugs | No Comments »
To continue our e-Prescribing 101 blog series, we shine light on controlled substances. What they are, their relationship to e-Prescribing, as well as the correlation between prescription drugs and the current opioid epidemic.
What is a controlled substance?
A controlled substance is a drug or chemical, such as illicitly used drugs or prescription medications, that is regulated by a government based on the drug or chemical’s manufacture, possession, or use.
Why are certain drugs categorized as a controlled substance?
A drug is typically classified as “controlled” due to the potential detrimental effects on a person’s health and well-being. As a result, state and federal governments have seen fit to regulate such substances.
It’s for this reason that drugs, substances, and certain chemicals used to make drugs of this caliber are classified into five categories. The drug segregation is dependent upon the drug’s acceptable medical use and the drug’s abuse or dependency potential.
What are the medication schedules for controlled substances?
Schedule I
- Drugs with no currently accepted medical use and hold a high potential for abuse.
- Examples: Heroin, Marijuana (Cannabis), LSD, and Ecstasy
Schedule II
- Includes drugs that are accepted for medical use, but have a high potential for abuse, with use potentially leading to severe psychological or physical dependence.
- Examples: Vicodin, OxyContin, Adderall, and Ritalin
Schedule III
- Drugs with a moderate to low potential for physical and psychological dependence, with less abuse potential than Schedule I or Schedule II drugs.
- Examples: anabolic steroids, testosterone, and Tylenol with codeine
Schedule IV
- Drugs within this category have a low potential for abuse and dependence.
- Examples: benzodiazepines (Xanax, Valium, Ativan), Tramadol, and Ambien
Schedule V
- The lowest schedule for controlled substances, these drugs have lower potential for abuse and consist of preparations containing limited quantities of certain narcotics.
- Examples: Robitussin AC, Lyrica, and Motofen
What is EPCS?
EPCS stands for the Electronic Prescribing of Controlled Substances and is a technology that has been put into place to help address the rising issue of prescription drug abuse in the United States.
Understanding two-factor authentication
This two-step process is part of EPCS and ensures that only an authorized prescriber can electronically sign and send controlled substance prescriptions to a pharmacy, thus increasing patient safety. The process includes the entry of something you have, such as a token generated one-time code, and something you know, like a password. There are various options for two-factor authentication including: fob tokens, mobile phone applications, smart cards, USB thumb drives, and fingerprint scanners.
What is an opioid?
Opioids are substances that act on the body’s opioid receptors to produce euphoric effects, better known as a “high”, and are most often used medically to treat moderate to severe pain that may not respond well to other pain medications.
Why are opioids so addictive?
Opioid drugs work by binding opioid receptors in the brain, spinal cord, and other areas of the body to reduce the sending of pain messages to the brain, thus simultaneously reducing the physical feelings of said pain. They create artificial endorphins, the body’s natural painkillers, which tap into the “reward” sector of someone’s brain. However, with chronic use, opioids eventually trick the brain into stopping the production of these endorphins naturally. In doing so, the tolerance level increases and a patient is left with taking more medication to achieve the same effect.
They are most dangerous when taken in certain ways to increase the “high”, such as crushing pills and then snorting or injecting the powder, or combining the pills with alcohol or drugs, especially benzodiazepines. While some patients do take them for their intended purpose, they can still risk dangerous adverse reactions by not taking them exactly as prescribed, i.e. they take more at one time, or combine them with other medications not checked by their doctor.
Unfortunately, the fear of the intense withdrawal symptoms is often the biggest culprit when it comes to patients remaining addicted and ultimately leads them to continue taking the medication even if they no longer want to.
The correlation between prescription opioids and the opioid epidemic
In 2012 alone, 259 million prescriptions were written for opioids, which is more than enough to give every American adult their own bottle of pills. In comparison to ten, even five years ago, this number is dramatically increasing as time goes on and more and more opioid overdoses are being reported on a daily basis.
Physicians and dentists are collectively responsible for providing 81.6% of opioid prescriptions in the United States and because of this, they have a very unique role in mitigating the impact of this opioid epidemic. Opioid addiction often starts at the hands of healthcare professionals simply trying to do their job, prescribing pain medications to relieve their patients of painful woes, especially during post-operative recovery.
While many prescriptions are meant for initial, short-term treatment, some doctors and dentists authorize refills time and time again because they want to help patients whom claim that they are still in pain. However, when the pill bottle and refills run out, patients are left seeking alternatives to create that euphoric escape they’ve become so accustomed to. This could mean an endless search of several different doctors to prescribe more substances (also known as doctor shopping), purchasing pills on the black market, or worse, turning to heroin as a cheaper and more readily available alternative.
Furthermore, the associated stigma often deters patients from receiving proper rehabilitation treatment and even if they do seek treatment, the government currently limits the number of patients a single provider may treat with drugs such as buprenorphine or methadone, which are both proven to reduce cravings and save lives. This leads to many patients relapsing.
How does e-Prescribing help?
- e-Prescribing diminishes the possibilities of duplicate or lost prescriptions since the prescription is sent directly to the patient’s pharmacy.
- A patient will no longer have a paper prescription where the dispense quantity can be altered.
- Prescriber’s will have access to a patient’s medication history, therefore they can determine if a patient is doctor shopping or has a history of substance abuse.
Don’t miss the other parts of our e-Prescribing 101 series:
e-Prescribing 101, Part I:Â The Basics
e-Prescribing 101, Part III: End Users
Sources: DEA; DrugAbuse.gov; FDA
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: January 26th, 2017 | Author: Shauna | Filed under: Basics, Controlled Substances, Dental, Digital Health, Medical, Telehealth | Tags: e-Prescribing, e-Prescribing 101, e-Prescribing Basics, e-Prescribing controlled substances, e-Prescribing Integration, e-Prescribing Integration Platforms, e-Prescribing Software, EHR, Electronic Health Record, Electronic Medical Record, EMR, EPCS, Health Care Software, Health Care Software Companies, Practice Management Software, surescripts | No Comments »
Another year has come and gone. Time to start fresh, gain new perspective, and bring it back to basics. e-Prescribing basics, that is.
During our reflection on 2016, the DoseSpot realized that there’s so much information out there regarding e-Prescribing and its different components; so many key opinion leaders and incredible resources to tap into to help educate the world about e-Prescribing. However, how could we make it easier? How can we assist those who just want to learn more about e-Prescribing in general without the endless Google searches?
That’s why we decided to create a three-part blog series covering all e-Prescribing basics; a one-stop-shop to answer all of your e-Prescribing questions and curiosities.
We can promise you this – this is one New Year’s resolution we won’t give up on.
Let’s get started.
What is e-Prescribing?
The term e-Prescribing has become a popular buzzword in the healthcare industry, but what exactly does it mean? To put it simply, electronic prescribing, known in short as e-Prescribing, is a method of prescription transaction that allows prescribers to write and send prescriptions to pharmacies electronically instead of writing, phoning-in, or faxing. It ultimately replaces the costly paper prescription pad and tamper-proof printing paper from a prescriber’s office for good.
e-Prescribing solutions have the following capabilities:
- NewRx: Route new prescriptions to the patient’s pharmacy of choice.
- Refills: Receive prescription renewal requests and submit responses between doctor and pharmacy.
- Medication History: View aggregated medication history data from pharmacies and pharmacy benefit managers (PBMs) upon receipt of patient consent.
- Prescription Benefit: Surescripts’ Prescription Benefit service puts eligibility, benefits and formulary information at a prescriber’s fingertips at the time of prescribing. This enables prescribers to select medications that are on formulary and are covered by the patient’s drug benefit.
- Electronic Prescribing of Controlled Substances (EPCS): Product has achieved Surescripts EPCS certification and has provided third-party audit documentation as required by the DEA.
What are the benefits?
e-Prescribing is not just the ability to send prescriptions electronically to pharmacies. It can also increase care quality in a number of ways:
- Eliminates the time and effort of trying to understand the prescriber’s handwriting, as well as the chance of an error in that translation.
- Makes sure that the prescriber is providing enough specific information for the pharmacist to fill the prescription, including the name of the drug, the dosage, its physical form, the route, and the prescriber’s instructions.
- Ensures that any drug-drug and drug-allergy interactions based on a patient’s medication history are found and reported to the prescriber before the prescription order is completed.
- Checks a patient’s pharmacy benefit and associated formulary at point of care to encourage the prescriber to choose the best medication option, both medically and financially.
- Increases patient medication pick-up adherence. Between 28% and 31% of all paper prescriptions either never make it to the pharmacy, or are not picked up once patients see how much it will cost.
- Drives down healthcare costs and improves patient satisfaction by getting medications to patients in a timely, convenient, and secure manner at the patient’s pharmacy of choice.
- Curbs prescription drug abuse and increases patient safety. No longer will a patient have access to a paper prescription, therefore no more altered dispense quantities, stolen prescription pads, or lost or duplicate prescriptions.
- Lowers costs associated with purchasing expensive paper prescription pads and the time and resources spent on redundant administrative tasks.
- Simplifies clinical workflows and allows prescribers to do what they do best and spend more time with their patients.
Who can e-Prescribe?
State or provincial legislation governs who can write a prescription, and under these rulings, any licensed physician, dentist, nurse practitioner, etc. allowed to write prescriptions by hand can also prescribe electronically.
Many electronic prescribing vendors also allow the use of proxy users, such as nurses, medical assistants, or office staff. While they cannot legally send a prescription to a pharmacy, they are able to access the e-Prescribing solution and fill in all required fields of the prescription for a prescriber to then approve and send.
What pharmacies allow e-Prescribing?
All 50 states and D.C. allow the e-Prescribing of both controlled and non-controlled substances and more than 90% of pharmacies can receive e-Prescriptions. Of course this includes the larger retail pharmacy chains such as CVS and Walgreens and mail-order pharmacies like Catamaran and Express Scripts.
Don’t miss the other parts of our e-Prescribing 101 series:
e-Prescribing 101, Part II: Controlled Substances
e-Prescribing 101, Part III: End Users
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: November 8th, 2016 | Author: Shauna | Filed under: Basics, Controlled Substances, Dental | Tags: Controlled Substances, DEA, Dental, Dental e-Prescribing, dental practice management, e-Prescribing controlled substances, e-Prescribing Integration, e-Prescribing Software, electronic prescribing, EPCS, health IT, healthcare IT, Healthcare Software, healthIT, Opioid Epidemic, Opioids, Patient Engagement, technology, trends, Value Based Care | No Comments »
Unfortunately, the opioid epidemic that is currently grappling the United States isn’t exactly news. Headlines appear on a daily basis in regards to this addiction, the overdoses and fatalities, as well as the healthcare community’s contribution to this crisis, both the good and the bad.
We’ve seen Congress, the Surgeon General, and many other organizations make extreme efforts to combat this crisis, yet despite the widespread media attention, many healthcare professionals still don’t realize how dangerous the drugs can be or how addictive they are.
DoseSpot recently conducted a live webinar in an effort to educate and discuss the critical role that dentists in particular play in mitigating the current opioid epidemic that is upon us and during that time, the following crucial points were made:
The blame game needs to stop
Blaming others only diverts the necessary action of collectively coming together as a nation, regardless of one’s associated industry. Healthcare, Law Enforcement, Politics – there needs to be a strong, unified foundation for which we can assemble and fight this battle together.
Break the habit: prescribing patterns of pain medication
Dentists serve a unique role in overcoming this epidemic due to the nature of their work and the procedures they perform, specifically wisdom teeth extraction. It’s a fair statement that the majority do not enter the healthcare industry with ill intent of harming their patients, yet it’s also fair to say that lack of proper education and prior pharmaceutical marketing tactics have fueled poor prescribing patterns. In order to change one’s behavior, programmed thoughts and approaches must be reevaluated.
Opioid addiction does not discriminate
This addiction can affect anyone regardless of one’s socioeconomic status or in some cases, a person’s relationship to their dentist. What DoseSpot coins as “The Insider Threat,” we reveal how certain folks pose a potential risk relative to obtaining controlled substances, both knowingly and secretively. Stories of addiction that are shared during our recent webinar further prove that opioids do not discriminate.
Solutions are available
The truth of the matter is, there is not one single solution that can work independently. It needs to be a collective effort and innovation is critical to success. There needs to be multifaceted solutions to tackle this complex problem ranging from increasing specialty training and education to proper treatment technology, data, and analytics.
To learn more on dentistry’s role in the opioid epidemic, watch the full webinar here.
Presenters:
Greg Waldstreicher, CEO, DoseSpot
Dr. John Zweig, Chief Dental Officer, Dental Associates
Donald Whamond, Chief Technology Officer, Dental Associates
Jason Wolan, Director of EHR Implementation, Great Expressions Dental Centers
Daniel Smelter, Director of Business Analysis, Benevis, Inc.
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: October 27th, 2016 | Author: Shauna | Filed under: Basics, Controlled Substances, In the News, Public Policy, Security, Standards | Tags: Controlled Substances, DEA, DoseSpot, e-Prescribing, e-Prescribing controlled substances, e-Prescribing Integration, e-Prescribing Software, electronic prescribing, Healthcare Software, Opioid Epidemic, Opioids, Patient Engagement, PDMP, PMP, Prescription Drug Monitoring Program, Prescription Monitoring Program, State Mandates, trends, Value Based Care | No Comments »
On par with our last post, the widespread media attention and devastating losses associated with our nation’s current opioid epidemic has sparked certain state legislatures to regulate and improve providers’ prescribing habits for prescription painkillers.
With good intentions in tow, some rulings seem to lack readily available solutions that are proven to curb this crisis. However, they do realize that their recent proposals do not mark the end of this uphill battle, rather multifaceted solutions need to be in place to truly, and successfully, overcome this epidemic.
[Read: Overdose Awareness – The Time to Stand Together is Now]
Here are three states that have recently proposed rulings on how opioids should be prescribed:
Vermont
Coined as a “cutting-edge†approach to overcoming the opioid crisis, Governor Peter Schumlin announced proposed limits on the number of opioid medications that could be prescribed.
Like every other state, Vermont has seen an incredible increase in deaths related to opioid and heroin overdose in recent years and Governor Schumlin is no longer sitting on the sidelines.
Earlier this year, he approached both the FDA and pharmaceutical industry in his State of the State address claiming that OxyContin “lit the match that ignited America’s opiate and heroin addiction crisis,†and that the booming American opiate industry knows no shame, an outcry after the FDA approved OxyContin for children a few months ago.
The proposed ruling states that the severity and duration of pain will determine the specific limit for a prescription of opioids. For example, a minor procedure with moderate pain would be limited to 9-12 opioid pills and the amount would increase based on the procedure performed and the level of pain a patient claims. The ruling would also require providers to discuss risks, provide an education sheet to the patient and receive an informed consent for all first-time opioid prescriptions.
The Green Mountain State’s Governor believes that limiting the number of opioid pills prescribed would be an effective way to reduce addiction, yet some folks believe the ruling would only encourage patients to seek illicit drugs elsewhere if they cannot receive pain medication through their provider.
This does make sense considering many former and current heroin abusers have stated that their addiction started from a prescription and when the pill bottle ran out, they were left seeking these drugs on the streets, which have proven to be very, if not more, dangerous than the prescription.
However, the intent of the Governor’s ruling is to prevent addiction from ever happening in the first place. His ruling is specific to cases of acute pain, therefore changing the over-prescribing habits and learned behavior of utilizing opioids as first-line therapy; habits that ensued in large part due to incentives, the surge of pharmaceutical marketing tactics and claims that painkillers were not addictive.
[Read: How Costly Are Prescription Pain Meds?]
New Jersey
With the rate of drug overdose deaths on the rise by 137% since 2000, New Jersey is another state to recently propose new regulations on how and to whom opioids are prescribed.
New Jersey, much like many other states, believes that prevention is key when fighting this crisis and they couldn’t be more correct. Unfortunately, several barriers often occur when seeking appropriate treatment after a patient becomes addicted, (for example, providers are limited to certain amounts for which they can administer reversal drugs), and therefore why not PREVENT addiction, rather than simply TREAT addiction when at many times, it’s too late?
Senator Raymond Lesniak has introduced a bill that would put restrictions on health insurance coverage for opioid medications, while also requiring prescribers to first consider alternative pain-management treatments, follow federal prescribing guidelines and explain the risk of addiction with such substances to their patients before prescribing. Furthermore, providers will need to complete several steps before receiving approval of an opioid prescription. These steps include providing a patient’s medical history, conducting a physical exam and developing an appropriate medical plan for treating a patient’s pain.
While new rulings in place can certainly shift this epidemic, Angela Valente, the executive director of the Partnership for a Drug-Free New Jersey, said it best:
“Awareness and education is the key factor in preventing the abuse of opiates—everyone must have a role in reversing this epidemic, including lawmakers, parents, coaches, educators, and yes, even doctors and dentists.†– Angela Valente
Dr. Andrew Kolodny, executive director of Physicians Responsible for Opioid Prescribing, further backs Valente’s point while also motioning that the medical community has been prescribing too aggressively.
[Read: The Opioid Epidemic: Are Dentists the Black Sheep?]
Pennsylvania
Unfortunately, Pennsylvania experienced 3,500 deaths last year as a result from drug overdose, one of the highest overdose rates in the nation.
The state has had a Prescription Drug Monitoring Program for quite a few years now, however it wasn’t functional until August 2016, when their new program was officially rolled out. Pennsylvania requires providers to query the state’s prescription drug database the first time they prescribe a controlled substance to a patient or if they have reason to believe that the patient is doctor shopping.
Governor Tom Wolf addressed other initiatives underway including requiring providers to query the database EACH time they prescribe opioids, updating medical school curriculum and continuing education, changes to the process of pain care to lower inappropriate use of opioids, and improved screening, referral and treatment for addiction.
What’s bothersome in Pennsylvania, is the method in which these substances have to be prescribed. The Pennsylvania Controlled Substance Act requires narcotic prescriptions to be handwritten on paper prescription pads, yet every other substance can be electronically prescribed. This allows the risk of written prescriptions being lost, stolen, or sold. Luckily, Senator Richard Alloway intends to introduce this measure before the legislative session’s end.
It’s promising to see how the above states are utilizing their state’s Prescription Drug Monitoring Program, or PDMP. All three require their prescribers to query the affiliated state database, however the parameters in which, or how often, they check varies.
While said efforts are better than no effort at all and states are starting to fully understand the need for multifaceted solutions in order to overcome this epidemic, one key solution is missing. E-Prescribing.
[Read: The Link Between PDMP’s and e-Prescribing]
How does e-Prescribing help combat this epidemic?
- e-Prescribing diminishes the possibilities of duplicate or lost prescriptions since the prescription is sent directly to the patient’s pharmacy
- A patient will no longer have a paper prescription where the dispense quantity can be altered
- Prescribers will have access to a patient’s medication history, therefore they can determine if a patient is “doctor shopping†or has a history of substance abuse
To learn how to incorporate e-Prescribing as a solution to the opioid epidemic, schedule a meeting with DoseSpot today.
Sources:Â NY Times; Boston.com; ABC News; Press of Atlantic City; PennLive
About DoseSpot
DoseSpot is a Surescriptsâ„¢ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: October 19th, 2016 | Author: Shauna | Filed under: Basics, Telehealth | Tags: digital health, Docity, DoseSpot, e-Prescribing, e-Prescribing Integration, e-Prescribing Software, health IT, Healthcare Delivery Model, healthcare IT, Healthcare Software, healthIT, mhealth, Patient Centric Care, Patient Engagement, Press Release, surescripts, telehealth, telemedicine, trends, Value Based Care | No Comments »
NEEDHAM HEIGHTS, MA – Docity, a veteran-owned, connected telehealth platform that enables real time HIPAA-compliant communications between healthcare providers and patients, has announced their strategic, patient-driven integration of DoseSpot’s e-Prescribing solution.
The key component of Docity’s business model is simple: to put patients first by listening to their needs and adapting a digital healthcare system based on those needs.
“Docity’s business is driven solely by the patient-centric model and DoseSpot understood that crucial factor from the very beginning,” said James Cowan, CEO, Docity. “As part of this model, Docity knew that incorporating e-Prescribing was a non-negotiable. E-Prescribing isn’t just a feature; it’s something you must have in today’s competing market.”
Prior to integrating DoseSpot, Docity was offering their connected health platform to several clinics with existing patients, but prescribing was done on the clinician’s own terms. Since the integration with DoseSpot’s e-Prescribing solution, Docity will now be able to offer a comprehensive digital platform to serve the needs of individual patients on a subscription basis.
“The integration process with DoseSpot was a breeze,” Cowan added. “Their team was very flexible and actively engaged, working around the clock to ensure that Docity met al Surescripts certification requirements in a timely manner. Furthermore, they were able to work directly with our developers and their project management tool kept everyone organized which made for a seamless process overall.”
Docity is not only meeting the increasing demands of patients and providers, but the DoseSpot integration has better leveraged relationships with key stakeholders, primarily from a compliance perspective.
“Since integrating with DoseSpot, Docity has seen significant buy-in from highly sought after individuals, providers and companies in the healthcare community who are more eager than ever to stand behind our vision,” said Cowan. “It’s a win-win for both parties.”
“Our partnership with Docity is rooted in understanding and listening to both the patients’ and providers’ demands. Patient-centricity is a current healthcare trend we are committed to upholding as the healthcare landscape continues to evolve,” said Greg Waldstreicher, CEO, DoseSpot. “As a telehealth company, Docity recognized that e-Prescribing is a key component of the value-based delivery model and should be interwoven at the forefront to create a seamless healthcare experience for all involved.”
To learn more about how Docity is meeting the demands of the healthcare community with comprehensive and innovative solutions, please visit www.DoseSpot.com or contact Shauna Leighton, Shauna@DoseSpot.com.
About Docity
Docity Health is a connect health startup headquartered in Chattanooga, TN. Their mission is to connect providers with patients and patients with their health through on demand access to healthcare. For additional information please visit www.Docity.com.
About DoseSpot
DoseSpot is a Surescriptsâ„¢ certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.
Posted: October 6th, 2016 | Author: Shauna | Filed under: Controlled Substances, Digital Health, Telehealth | Tags: behavioral health, Care Coordination, Controlled Substances, DEA, Dental e-Prescribing, digital health, DoseSpot, e-Prescribing, e-Prescribing controlled substances, e-Prescribing Integration, e-Prescribing Software, EHR, EHR software, EPCS, Geriatric Care, Geriatrics, health IT, healthcare IT, Healthcare Software, healthIT, meaningful use, medication adherence, Opioid Epidemic, Opioids, Patient Engagement, technology, telehealth, telemedicine, trends, Value Based Care | No Comments »
It’s no surprise that technology should be considered a key player as we shift to value-based care. With smartphones, tablets and computers, health information is readily available for patients with a simple click of a button. Why should a consultation with a healthcare professional be any different?
Telehealth greatly increases the scope of the healthcare industry and is bound to open huge opportunities in increasing the quality of healthcare. The ultimate goal here, is to prevent hospital readmissions through better management of individuals with chronic conditions, while also reducing associated costs. By enabling remote patient monitoring and remote access to clinicians, market growth is inevitable as awareness and implementation of standards for reimbursement and adoptions of these care models expands.
While several reports claim that “technology gets in the way of the patient experience,†patients are in fact the ones demanding such access to care. This increase in patient demand for telehealth services has prompted many companies and healthcare organizations to think outside of the box and reevaluate the patient-centric model, while questioning what that care model really means to a patient.
Well, it’s simple. Patients want a customized, cost-effective and convenient healthcare experience to which telehealth can provide.
A recent report states that the global telehealth market was valued at $14.3 Billion in 2014 and is estimated to reach $36.3 Billion by 2020, growing at a CAGR of 14.30% from 2014 to 2020.
With these numbers in tow, we predict the most growth in three different segments:
Behavioral Health and Addiction
As mentioned in a previous post, telehealth has the ability to bridge the gaps in care of behavioral health patients and providers. Not only does it provide a convenient, more comfortable and less expensive medical consultation, but it broadens accessibility to patients whom may not have many options when seeking a behavioral health provider, especially in rural areas. Unfortunately, the lack of psychiatrists and addiction specialists across the nation, as well as the stigma often involved, are contributing to the mental health and addiction issues and creating barriers to appropriate care.
Patients will see their primary care physician and may not receive the exact treatment plan that they need; after all, primary care physicians do not specialize in behavioral health or addiction and often, these illnesses require a lot of time and patience to which the physician may not be able to accommodate. Telehealth will be able to connect patients in need with specialists regardless of their location who know how to treat these specific health issues.
This effective care model will not only lessen the hit on the nation’s bottom line as more and more individuals grapple with suicide, addiction, and other mental health issues, but also revolutionize the way people view the stigma involved and encourage patients to seek help as they are able to receive treatment from the comfort of their own home.
Geriatric Care
Geriatric patients stand to benefit tremendously as a digital health consumer. As mobility can be especially difficult for these patients, the ability to see a physician remotely removes one of the largest barriers to care. Furthermore, transporting patients of this age may potentially do more harm than good.
With telemedicine, providers can more quickly spot at-risk patients and provide interventions to avoid an otherwise unnecessary hospital admission. Similarly, nursing homes can partner with health systems to provide bedside care for their residents at a fraction of the price of an onsite physician.
These infrastructure synergies provide connectivity with electronic health records (EHRs) and create clear communication among hospitals, senior care facilities, referring physicians and patient families. They also provide the link to population based management databases and other health care analytic functions to measure value.
Surgery
Many surgical departments find telehealth to be a more convenient and cost-effective way for pre- and post- operative instructions for procedures of all magnitudes including wisdom teeth extraction, colonoscopies, stent placement and more.
With in-person visits and paper instructions, patients may misinterpret or even forget important information relative to their surgery. This includes what medications to stop taking and how to physically prepare for surgery, while providing a clear, direct line of answers for any questions a patient may have. With instructions digitally delivered prior to surgery, telehealth reduces patient no shows and saves valuable scheduled operating room time.
For post-op patients, providers can check the patient visually, ensuring that patients are following their treatment plans and making adjustments as needed. Through this continuous connection, providers are empowered to deliver the guidance that many patients need as they go through the healing process. These virtual check-ins ensure the patient is on the road to recovery, thus reducing readmission rates all without the patient ever having to leave their home.
Furthermore, telehealth can improve treatment and medication compliance, specifically with controlled substances, i.e. pain medication. Opioid addiction often begins at the hands of a prescriber and with the nation currently facing an opioid epidemic, marrying technology and follow-up appointments when prescribing these types of medications serves as the optimal solution for the safety of all involved.
Technology should no longer be viewed as a barrier to care, but rather embraced in order to improve the healthcare industry, including the improvement of interoperability as well as patient outcomes. Telehealth not only meets the ever increasing demands of patients, but it also assists in preventative care by creating greater access to such care, thus reducing down-the-road costs and burdensome associated with chronic disease. With many chronic diseases being completely preventable, the prevent vs. treat mantra should be sound in every healthcare professional’s mind, while realizing that telehealth is a seamless way of delivering healthcare for all involved.
There may currently be barriers in place regarding reimbursement from payers, but that’s sure to change as more and more payers jump on board for this new delivery model. After all, who’s to say telehealth won’t become the norm and be known as simply….health?
Sources:Â American Well; OpenPR; mHealth Intelligence; Healthcare IT News
About DoseSpot
DoseSpot is a Surescripts certified e-Prescribing platform specifically designed to integrate with electronic health record, electronic dental record, practice management and telehealth software. DoseSpot is certified to e-Prescribe controlled substances and has provided simple, affordable and integratable e-Prescribing solutions to healthcare IT companies since 2009. For more information, please visit www.DoseSpot.com.